Option Care Health, INC. (OPCH) — SEC Filings

Q: What are the key financial highlights for Option Care Health, INC.?

Key financial highlights for Option Care Health, INC. are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Option Care Health, INC.?

Key executives at Option Care Health, INC. are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Option Care Health, INC. stock?

Risk factors for Option Care Health, INC. (OPCH) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Option Care Health, INC.?

Forward-looking statements and predictions from Option Care Health, INC. are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Option Care Health, INC.. Recent ARS filing on Apr 8, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Option Care Health, INC. on SEC EDGAR

Overview

Option Care Health, INC. (OPCH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a ARS filed on Apr 8, 2026: Option Care Health, Inc. filed its Annual Report to Security Holders (ARS) on April 8, 2026, for the period ending December 31, 2025. The filing, with accession number 0001140361-26-013829, provides a comprehensive overview of the company's performance and financial standing for the fiscal year 2025

Sentiment Summary

Across 23 filings, the sentiment breakdown is: 1 bullish, 21 neutral, 1 mixed. The dominant filing sentiment for Option Care Health, INC. is neutral.

Filing Type Overview

Option Care Health, INC. (OPCH) has filed 1 ARS, 1 DEFA14A, 6 10-Q, 8 8-K, 2 DEF 14A, 2 10-K, 1 SC 13G, 2 SC 13G/A with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (23)

Option Care Health Files 2025 Annual Report — ARS · Apr 8, 2026 Risk: low
Option Care Health, Inc. filed its Annual Report to Security Holders (ARS) on April 8, 2026, for the period ending December 31, 2025. The filing, with accession
DEFA14A Filing — DEFA14A · Apr 8, 2026
Option Care Health Revenue Up, Net Income Dips Amid Acquisition Costs — 10-Q · Oct 30, 2025 Risk: medium
Option Care Health, Inc. (OPCH) reported a mixed financial performance for the nine months ended September 30, 2025. Net revenue increased by 14.57% to $4.184 b
Option Care Health Enters Material Definitive Agreement — 8-K · Sep 25, 2025 Risk: medium
On September 22, 2025, Option Care Health, Inc. entered into a material definitive agreement related to a direct financial obligation. The filing does not speci
Option Care Health Elects New Directors, Adjusts Compensation — 8-K · Aug 20, 2025 Risk: medium
Option Care Health, Inc. announced on August 19, 2025, a change in its board of directors and executive compensation arrangements. Specifically, the company ele
Option Care Health Q2 Revenue Jumps to $1.12B, Net Income Up 10.8% — 10-Q · Jul 30, 2025 Risk: low
Option Care Health, Inc. (OPCH) reported a robust financial performance for the second quarter ended June 30, 2025, with revenue reaching $1.12 billion, marking
Option Care Health Files 8-K with Routine Updates — 8-K · May 16, 2025 Risk: low
Option Care Health, Inc. filed an 8-K on May 14, 2025, reporting on several items including amendments to its articles of incorporation or bylaws, submission of
Option Care Health Files Q1 2025 10-Q — 10-Q · Apr 29, 2025 Risk: low
Option Care Health, Inc. filed its 10-Q report for the period ending March 31, 2025. The company, formerly known as BioScrip, Inc., is a home health care servic
Option Care Health Files Proxy Statement for Annual Meeting — DEF 14A · Apr 2, 2025 Risk: low
Option Care Health, Inc. filed its definitive proxy statement (DEF 14A) on April 2, 2025, for its annual meeting on May 14, 2025. The filing concerns the electi
Option Care Health Files 2024 10-K — 10-K · Feb 26, 2025 Risk: low
Option Care Health, Inc. filed its 2024 10-K on February 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as BioScri
Option Care Health Acquires Home Infusion Business — 8-K · Jan 13, 2025 Risk: medium
Option Care Health, Inc. announced on January 10, 2025, that it has entered into a definitive agreement to acquire substantially all of the assets of a home inf
SC 13G Filing — SC 13G · Nov 8, 2024
Option Care Health Files Q3 2024 10-Q — 10-Q · Oct 30, 2024 Risk: low
Option Care Health, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third
Option Care Health CEO, CFO Depart; New CEO Appointed — 8-K · Sep 6, 2024 Risk: medium
Option Care Health, Inc. announced on September 3, 2024, a series of executive changes. These include the appointment of John E. Tozzi as Chief Executive Office
Option Care Health Files Q2 2024 10-Q — 10-Q · Jul 31, 2024 Risk: low
Option Care Health, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second qua
Option Care Health Announces Board and Officer Changes — 8-K · May 17, 2024 Risk: medium
Option Care Health, Inc. announced on May 15, 2024, a change in its board of directors, with the election of new directors and the appointment of certain office
Option Care Health Enters Material Definitive Agreement — 8-K · May 10, 2024 Risk: medium
On May 8, 2024, Option Care Health, Inc. entered into a material definitive agreement related to a direct financial obligation. The company, formerly known as B
Option Care Health, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · Apr 23, 2024 Risk: medium
Option Care Health, Inc. (OPCH) filed a Quarterly Report (10-Q) with the SEC on April 23, 2024. Option Care Health, Inc. filed a 10-Q report for the period endi
Option Care Health Files Definitive Proxy Statement — DEF 14A · Apr 3, 2024 Risk: low
Option Care Health, Inc. (OPCH) filed a Proxy Statement (DEF 14A) with the SEC on April 3, 2024. Option Care Health served over 270,000 unique patients in 2023
Option Care Health Files 8-K — 8-K · Mar 14, 2024 Risk: low
Option Care Health, Inc. filed an 8-K on March 14, 2024, to disclose information under Regulation FD. The filing does not contain specific financial figures or
Option Care Health, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 22, 2024 Risk: low
Option Care Health, Inc. (OPCH) filed a Annual Report (10-K) with the SEC on February 22, 2024. Option Care Health, Inc. filed its annual report on Form 10-K fo
Vanguard Discloses 13.5% Stake in Option Care Health — SC 13G/A · Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in Option Care Health Inc. As of December
BlackRock Amends Option Care Health Stake as of Dec 31, 2023 — SC 13G/A · Jan 23, 2024
BlackRock Inc. filed an amended SC 13G/A on January 23, 2024, disclosing its ownership of Option Care Health, Inc. common stock as of December 31, 2023. This fi

Risk Profile

Risk Assessment: Of OPCH's 20 recent filings, 0 were flagged as high-risk, 8 as medium-risk, and 12 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Option Care Health, INC.'s most recent 10-Q filing (Oct 30, 2025):

Revenue: $4.184B
Net Income: $149.081M
EPS: $0.91
Debt-to-Equity: 1.56
Cash Position: $309.822M
Operating Margin: 5.90%
Total Assets: $3.480B
Total Debt: $1.162B

Key Executives

John E. Tozzi
John C. Raducha
Michael A. Ruggiero
Michael J. Ruggiero
Michael J. Ruggiero Jr.

Industry Context

Option Care Health operates in the home healthcare and infusion services sector, a market characterized by increasing demand for post-acute care and specialized therapies delivered in patient homes. The industry faces evolving reimbursement models, regulatory scrutiny, and consolidation pressures. Key trends include the shift towards value-based care, technological advancements in remote patient monitoring, and the growing need for services catering to chronic and complex conditions.

Top Tags

healthcare (6) · 10-Q (4) · governance (3) · financials (3) · Option Care Health (3) · Healthcare Services (2) · Revenue Growth (2) · material-definitive-agreement (2) · financial-obligation (2) · 10-K (2)

Key Numbers

Fiscal Year End: 2025-12-31 — The period covered by the Annual Report to Security Holders.
Net Revenue: $4.184B — Increased by 14.57% for the nine months ended September 30, 2025, compared to $3.652 billion in 2024.
Net Income: $149.081M — Decreased by 1.72% for the nine months ended September 30, 2025, from $151.690 million in 2024.
Cash and Cash Equivalents: $309.822M — Decreased by 25.09% from $412.565 million at December 31, 2024.
Intramed Plus Acquisition Cost: $117.2M — Completed on January 24, 2025, contributing to increased goodwill and cash outflow.
Company Stock Purchases: $214.887M — Significant cash outflow for the nine months ended September 30, 2025.
Largest Payer Revenue Concentration: 14% — Represents a concentration risk for the three and nine months ended September 30, 2025.
Pharmaceutical Vendor Concentration: 67% — Purchases from four vendors for the nine months ended September 30, 2025, indicating supply chain risk.
Long-term Debt, Net: $1.155B — Increased by $50.415 million from $1.104 billion at December 31, 2024.
Goodwill: $1.607B — Increased by $66.4 million from $1.540 billion at December 31, 2024, partly due to the Intramed Plus acquisition.
Diluted EPS: $0.91 — Increased from $0.87 for the nine months ended September 30, 2024, despite lower net income, due to fewer outstanding shares.
Q2 2025 Revenue: $1.12B — Increased from $1.05B in Q2 2024, showing 6.7% growth.
Q2 2025 Net Income: $65.3M — Up from $58.9M in Q2 2024, representing a 10.8% increase.
Six-Month 2025 Revenue: $2.21B — Increased from $2.07B in the prior-year period, indicating sustained growth.
Six-Month 2025 Net Income: $128.1M — Grew from $115.5M in the prior-year period, reflecting improved profitability.

Forward-Looking Statements

{"claim":"Vanguard will maintain a significant, passive stake in Option Care Health for the foreseeable future.","entity":"The Vanguard Group","targetDate":"2025-12-31","confidence":"high"}

Related Companies

AMED · LH · UNH

Frequently Asked Questions

What are the latest SEC filings for Option Care Health, INC. (OPCH)?

Option Care Health, INC. has 23 recent SEC filings from Jan 2024 to Apr 2026, including 8 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of OPCH filings?

Across 23 filings, the sentiment breakdown is: 1 bullish, 21 neutral, 1 mixed. The dominant sentiment is neutral.

Where can I find Option Care Health, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Option Care Health, INC. (OPCH) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Option Care Health, INC.?

Key financial highlights from Option Care Health, INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for OPCH?

The investment thesis for OPCH includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Option Care Health, INC.?

Key executives identified across Option Care Health, INC.'s filings include John E. Tozzi, John C. Raducha, Michael A. Ruggiero, Michael J. Ruggiero, Michael J. Ruggiero Jr..

What are the main risk factors for Option Care Health, INC. stock?

Of OPCH's 20 assessed filings, 0 were flagged high-risk, 8 medium-risk, and 12 low-risk.

What are recent predictions and forward guidance from Option Care Health, INC.?

Recent forward-looking statements from Option Care Health, INC. include guidance on {"claim":"Vanguard will maintain a significant, passive stake in Option Care Health for the foreseeable future.","entity.